ReviewEuropean journal of nuclear medicine and molecular imaging2025

The role of PSMA-based radioligand therapy in hormone-sensitive prostate cancer.

Riccardo Laudicella et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.